| Zacks Company Profile for China Health Industries Holdings, Inc. (CHHE : OTC) |
|
|
| |
| • Company Description |
| China Health Industries Holdings Inc. is a manufacturer of health food products through its subsidiaries Harbin Humankind Biology Technology Co., Limited and Heilongjiang Huimeijia Pharmaceutical Co., Ltd. The Company's operating segments consists of Humankind, HLJ Huimeijia and others. Humankind is engaged in the manufacturing and sale of health products. HLJ Huimeijia is involved in the manufacturing and distribution of tincture; ointments; rubber paste, including hormones; topical solution, suppositories, liniment, including traditional Chinese medicine extractions; enemas and oral liquids. China Health Industries Holdings Inc. is based in Harbin City, the Peoples Republic of China.
Number of Employees: 49 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $0.12 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 0 shares |
| Shares Outstanding: (millions) |
| Market Capitalization: $ (millions) |
| Beta: 0.67 |
| 52 Week High: $0.50 |
| 52 Week Low: $0.12 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
0.00% |
12.64% |
| 12 Week |
0.00% |
9.94% |
| Year To Date |
0.00% |
22.18% |
|
|
|
|
| |
|
|
| |
| • General Corporate Information |
Officers
Xin Sun - Chairman (sole director); Chief Executive Officer;
- - -
- - -
- - -
- - -
|
|
Peer Information
China Health Industries Holdings, Inc. (CORR.)
China Health Industries Holdings, Inc. (RSPI)
China Health Industries Holdings, Inc. (CGXP)
China Health Industries Holdings, Inc. (BGEN)
China Health Industries Holdings, Inc. (GTBP)
China Health Industries Holdings, Inc. (RGRX)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 169398104
SIC: 2834
|
|
Fiscal Year
Fiscal Year End: June
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 09/19/22
|
|
Share - Related Items
Shares Outstanding:
Most Recent Split Date: (:1)
Beta: 0.67
Market Capitalization: $ (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $ |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 09/19/22 |
|
|
|
| |
